Chidamide Combined With VDDT Regimen in the Relapse and Refractory Diffuse Large B Cell Lymphoma
Status:
Unknown status
Trial end date:
2021-05-01
Target enrollment:
Participant gender:
Summary
This is a prospective phase II clinical trial to observe the efficacy and safety of Chidamide
combined with VDDT(vinorelbine，liposomal doxorubicin，dexamethasone and thalidomide) in
relapsed and refractory patients with diffuse large B-cell lymphoma(DLBCL).